Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
5,401
archived clinical trials in
Alzheimer Disease

Progress of Mild Alzheimer's Disease in Participants on Solanezumab Versus Placebo
Effect of Passive Immunization on the Progression of Mild Alzheimer's Disease: Solanezumab (LY2062430) Versus Placebo
Status: Enrolling
Updated:  4/2/2018
Alexian Brothers Medical Center
mi
from
Elk Grove Village, IL
Progress of Mild Alzheimer's Disease in Participants on Solanezumab Versus Placebo
Effect of Passive Immunization on the Progression of Mild Alzheimer's Disease: Solanezumab (LY2062430) Versus Placebo
Status: Enrolling
Updated: 4/2/2018
Alexian Brothers Medical Center
mi
from
Elk Grove Village, IL
Click here to add this to my saved trials
Progress of Mild Alzheimer's Disease in Participants on Solanezumab Versus Placebo
Effect of Passive Immunization on the Progression of Mild Alzheimer's Disease: Solanezumab (LY2062430) Versus Placebo
Status: Enrolling
Updated:  4/2/2018
Indiana University School of Medicine
mi
from
Indianapolis, IN
Progress of Mild Alzheimer's Disease in Participants on Solanezumab Versus Placebo
Effect of Passive Immunization on the Progression of Mild Alzheimer's Disease: Solanezumab (LY2062430) Versus Placebo
Status: Enrolling
Updated: 4/2/2018
Indiana University School of Medicine
mi
from
Indianapolis, IN
Click here to add this to my saved trials
Progress of Mild Alzheimer's Disease in Participants on Solanezumab Versus Placebo
Effect of Passive Immunization on the Progression of Mild Alzheimer's Disease: Solanezumab (LY2062430) Versus Placebo
Status: Enrolling
Updated:  4/2/2018
University of Kansas Medical Center
mi
from
Kansas City, KA
Progress of Mild Alzheimer's Disease in Participants on Solanezumab Versus Placebo
Effect of Passive Immunization on the Progression of Mild Alzheimer's Disease: Solanezumab (LY2062430) Versus Placebo
Status: Enrolling
Updated: 4/2/2018
University of Kansas Medical Center
mi
from
Kansas City, KA
Click here to add this to my saved trials
Progress of Mild Alzheimer's Disease in Participants on Solanezumab Versus Placebo
Effect of Passive Immunization on the Progression of Mild Alzheimer's Disease: Solanezumab (LY2062430) Versus Placebo
Status: Enrolling
Updated:  4/2/2018
CTT Consultants
mi
from
Prairie Village, KA
Progress of Mild Alzheimer's Disease in Participants on Solanezumab Versus Placebo
Effect of Passive Immunization on the Progression of Mild Alzheimer's Disease: Solanezumab (LY2062430) Versus Placebo
Status: Enrolling
Updated: 4/2/2018
CTT Consultants
mi
from
Prairie Village, KA
Click here to add this to my saved trials
Progress of Mild Alzheimer's Disease in Participants on Solanezumab Versus Placebo
Effect of Passive Immunization on the Progression of Mild Alzheimer's Disease: Solanezumab (LY2062430) Versus Placebo
Status: Enrolling
Updated:  4/2/2018
Heartland Research Associates, LLC
mi
from
Wichita, KA
Progress of Mild Alzheimer's Disease in Participants on Solanezumab Versus Placebo
Effect of Passive Immunization on the Progression of Mild Alzheimer's Disease: Solanezumab (LY2062430) Versus Placebo
Status: Enrolling
Updated: 4/2/2018
Heartland Research Associates, LLC
mi
from
Wichita, KA
Click here to add this to my saved trials
Progress of Mild Alzheimer's Disease in Participants on Solanezumab Versus Placebo
Effect of Passive Immunization on the Progression of Mild Alzheimer's Disease: Solanezumab (LY2062430) Versus Placebo
Status: Enrolling
Updated:  4/2/2018
Via Christi Regional Medical Center
mi
from
Wichita, KA
Progress of Mild Alzheimer's Disease in Participants on Solanezumab Versus Placebo
Effect of Passive Immunization on the Progression of Mild Alzheimer's Disease: Solanezumab (LY2062430) Versus Placebo
Status: Enrolling
Updated: 4/2/2018
Via Christi Regional Medical Center
mi
from
Wichita, KA
Click here to add this to my saved trials
Progress of Mild Alzheimer's Disease in Participants on Solanezumab Versus Placebo
Effect of Passive Immunization on the Progression of Mild Alzheimer's Disease: Solanezumab (LY2062430) Versus Placebo
Status: Enrolling
Updated:  4/2/2018
Baptist Physician's Lexington
mi
from
Lexington, KY
Progress of Mild Alzheimer's Disease in Participants on Solanezumab Versus Placebo
Effect of Passive Immunization on the Progression of Mild Alzheimer's Disease: Solanezumab (LY2062430) Versus Placebo
Status: Enrolling
Updated: 4/2/2018
Baptist Physician's Lexington
mi
from
Lexington, KY
Click here to add this to my saved trials
Progress of Mild Alzheimer's Disease in Participants on Solanezumab Versus Placebo
Effect of Passive Immunization on the Progression of Mild Alzheimer's Disease: Solanezumab (LY2062430) Versus Placebo
Status: Enrolling
Updated:  4/2/2018
Private Office: J. Gary Booker
mi
from
Shreveport, LA
Progress of Mild Alzheimer's Disease in Participants on Solanezumab Versus Placebo
Effect of Passive Immunization on the Progression of Mild Alzheimer's Disease: Solanezumab (LY2062430) Versus Placebo
Status: Enrolling
Updated: 4/2/2018
Private Office: J. Gary Booker
mi
from
Shreveport, LA
Click here to add this to my saved trials
Progress of Mild Alzheimer's Disease in Participants on Solanezumab Versus Placebo
Effect of Passive Immunization on the Progression of Mild Alzheimer's Disease: Solanezumab (LY2062430) Versus Placebo
Status: Enrolling
Updated:  4/2/2018
Maine Research Associates
mi
from
Auburn, ME
Progress of Mild Alzheimer's Disease in Participants on Solanezumab Versus Placebo
Effect of Passive Immunization on the Progression of Mild Alzheimer's Disease: Solanezumab (LY2062430) Versus Placebo
Status: Enrolling
Updated: 4/2/2018
Maine Research Associates
mi
from
Auburn, ME
Click here to add this to my saved trials
Progress of Mild Alzheimer's Disease in Participants on Solanezumab Versus Placebo
Effect of Passive Immunization on the Progression of Mild Alzheimer's Disease: Solanezumab (LY2062430) Versus Placebo
Status: Enrolling
Updated:  4/2/2018
Maine Neurology
mi
from
Scarborough, ME
Progress of Mild Alzheimer's Disease in Participants on Solanezumab Versus Placebo
Effect of Passive Immunization on the Progression of Mild Alzheimer's Disease: Solanezumab (LY2062430) Versus Placebo
Status: Enrolling
Updated: 4/2/2018
Maine Neurology
mi
from
Scarborough, ME
Click here to add this to my saved trials
Progress of Mild Alzheimer's Disease in Participants on Solanezumab Versus Placebo
Effect of Passive Immunization on the Progression of Mild Alzheimer's Disease: Solanezumab (LY2062430) Versus Placebo
Status: Enrolling
Updated:  4/2/2018
Pharmasite Research
mi
from
Baltimore, MD
Progress of Mild Alzheimer's Disease in Participants on Solanezumab Versus Placebo
Effect of Passive Immunization on the Progression of Mild Alzheimer's Disease: Solanezumab (LY2062430) Versus Placebo
Status: Enrolling
Updated: 4/2/2018
Pharmasite Research
mi
from
Baltimore, MD
Click here to add this to my saved trials
Progress of Mild Alzheimer's Disease in Participants on Solanezumab Versus Placebo
Effect of Passive Immunization on the Progression of Mild Alzheimer's Disease: Solanezumab (LY2062430) Versus Placebo
Status: Enrolling
Updated:  4/2/2018
McLean Hospital
mi
from
Belmont, MA
Progress of Mild Alzheimer's Disease in Participants on Solanezumab Versus Placebo
Effect of Passive Immunization on the Progression of Mild Alzheimer's Disease: Solanezumab (LY2062430) Versus Placebo
Status: Enrolling
Updated: 4/2/2018
McLean Hospital
mi
from
Belmont, MA
Click here to add this to my saved trials
Progress of Mild Alzheimer's Disease in Participants on Solanezumab Versus Placebo
Effect of Passive Immunization on the Progression of Mild Alzheimer's Disease: Solanezumab (LY2062430) Versus Placebo
Status: Enrolling
Updated:  4/2/2018
Boston University Medical Center
mi
from
Boston, MA
Progress of Mild Alzheimer's Disease in Participants on Solanezumab Versus Placebo
Effect of Passive Immunization on the Progression of Mild Alzheimer's Disease: Solanezumab (LY2062430) Versus Placebo
Status: Enrolling
Updated: 4/2/2018
Boston University Medical Center
mi
from
Boston, MA
Click here to add this to my saved trials
Progress of Mild Alzheimer's Disease in Participants on Solanezumab Versus Placebo
Effect of Passive Immunization on the Progression of Mild Alzheimer's Disease: Solanezumab (LY2062430) Versus Placebo
Status: Enrolling
Updated:  4/2/2018
Brigham and Women's Hosp
mi
from
Boston, MA
Progress of Mild Alzheimer's Disease in Participants on Solanezumab Versus Placebo
Effect of Passive Immunization on the Progression of Mild Alzheimer's Disease: Solanezumab (LY2062430) Versus Placebo
Status: Enrolling
Updated: 4/2/2018
Brigham and Women's Hosp
mi
from
Boston, MA
Click here to add this to my saved trials
Progress of Mild Alzheimer's Disease in Participants on Solanezumab Versus Placebo
Effect of Passive Immunization on the Progression of Mild Alzheimer's Disease: Solanezumab (LY2062430) Versus Placebo
Status: Enrolling
Updated:  4/2/2018
ActivMed Practices & Research
mi
from
Methuen, MA
Progress of Mild Alzheimer's Disease in Participants on Solanezumab Versus Placebo
Effect of Passive Immunization on the Progression of Mild Alzheimer's Disease: Solanezumab (LY2062430) Versus Placebo
Status: Enrolling
Updated: 4/2/2018
ActivMed Practices & Research
mi
from
Methuen, MA
Click here to add this to my saved trials
Progress of Mild Alzheimer's Disease in Participants on Solanezumab Versus Placebo
Effect of Passive Immunization on the Progression of Mild Alzheimer's Disease: Solanezumab (LY2062430) Versus Placebo
Status: Enrolling
Updated:  4/2/2018
Boston Center for Memory
mi
from
Newton, MA
Progress of Mild Alzheimer's Disease in Participants on Solanezumab Versus Placebo
Effect of Passive Immunization on the Progression of Mild Alzheimer's Disease: Solanezumab (LY2062430) Versus Placebo
Status: Enrolling
Updated: 4/2/2018
Boston Center for Memory
mi
from
Newton, MA
Click here to add this to my saved trials
Progress of Mild Alzheimer's Disease in Participants on Solanezumab Versus Placebo
Effect of Passive Immunization on the Progression of Mild Alzheimer's Disease: Solanezumab (LY2062430) Versus Placebo
Status: Enrolling
Updated:  4/2/2018
Northern Michigan Neurology
mi
from
Traverse City, MI
Progress of Mild Alzheimer's Disease in Participants on Solanezumab Versus Placebo
Effect of Passive Immunization on the Progression of Mild Alzheimer's Disease: Solanezumab (LY2062430) Versus Placebo
Status: Enrolling
Updated: 4/2/2018
Northern Michigan Neurology
mi
from
Traverse City, MI
Click here to add this to my saved trials
Progress of Mild Alzheimer's Disease in Participants on Solanezumab Versus Placebo
Effect of Passive Immunization on the Progression of Mild Alzheimer's Disease: Solanezumab (LY2062430) Versus Placebo
Status: Enrolling
Updated:  4/2/2018
Hattiesburg Clinic
mi
from
Hattiesburg, MS
Progress of Mild Alzheimer's Disease in Participants on Solanezumab Versus Placebo
Effect of Passive Immunization on the Progression of Mild Alzheimer's Disease: Solanezumab (LY2062430) Versus Placebo
Status: Enrolling
Updated: 4/2/2018
Hattiesburg Clinic
mi
from
Hattiesburg, MS
Click here to add this to my saved trials
Progress of Mild Alzheimer's Disease in Participants on Solanezumab Versus Placebo
Effect of Passive Immunization on the Progression of Mild Alzheimer's Disease: Solanezumab (LY2062430) Versus Placebo
Status: Enrolling
Updated:  4/2/2018
Univ of Nebraska Med Ctr
mi
from
Omaha, NE
Progress of Mild Alzheimer's Disease in Participants on Solanezumab Versus Placebo
Effect of Passive Immunization on the Progression of Mild Alzheimer's Disease: Solanezumab (LY2062430) Versus Placebo
Status: Enrolling
Updated: 4/2/2018
Univ of Nebraska Med Ctr
mi
from
Omaha, NE
Click here to add this to my saved trials
Progress of Mild Alzheimer's Disease in Participants on Solanezumab Versus Placebo
Effect of Passive Immunization on the Progression of Mild Alzheimer's Disease: Solanezumab (LY2062430) Versus Placebo
Status: Enrolling
Updated:  4/2/2018
Cleveland Clinic - Las Vegas
mi
from
Las Vegas, NV
Progress of Mild Alzheimer's Disease in Participants on Solanezumab Versus Placebo
Effect of Passive Immunization on the Progression of Mild Alzheimer's Disease: Solanezumab (LY2062430) Versus Placebo
Status: Enrolling
Updated: 4/2/2018
Cleveland Clinic - Las Vegas
mi
from
Las Vegas, NV
Click here to add this to my saved trials
Progress of Mild Alzheimer's Disease in Participants on Solanezumab Versus Placebo
Effect of Passive Immunization on the Progression of Mild Alzheimer's Disease: Solanezumab (LY2062430) Versus Placebo
Status: Enrolling
Updated:  4/2/2018
Las Vegas Radiology
mi
from
Las Vegas, NV
Progress of Mild Alzheimer's Disease in Participants on Solanezumab Versus Placebo
Effect of Passive Immunization on the Progression of Mild Alzheimer's Disease: Solanezumab (LY2062430) Versus Placebo
Status: Enrolling
Updated: 4/2/2018
Las Vegas Radiology
mi
from
Las Vegas, NV
Click here to add this to my saved trials
Progress of Mild Alzheimer's Disease in Participants on Solanezumab Versus Placebo
Effect of Passive Immunization on the Progression of Mild Alzheimer's Disease: Solanezumab (LY2062430) Versus Placebo
Status: Enrolling
Updated:  4/2/2018
AdvanceMed Research
mi
from
Lawrenceville, NJ
Progress of Mild Alzheimer's Disease in Participants on Solanezumab Versus Placebo
Effect of Passive Immunization on the Progression of Mild Alzheimer's Disease: Solanezumab (LY2062430) Versus Placebo
Status: Enrolling
Updated: 4/2/2018
AdvanceMed Research
mi
from
Lawrenceville, NJ
Click here to add this to my saved trials
Progress of Mild Alzheimer's Disease in Participants on Solanezumab Versus Placebo
Effect of Passive Immunization on the Progression of Mild Alzheimer's Disease: Solanezumab (LY2062430) Versus Placebo
Status: Enrolling
Updated:  4/2/2018
Albuquerque Neurosciences
mi
from
Albuquerque, NM
Progress of Mild Alzheimer's Disease in Participants on Solanezumab Versus Placebo
Effect of Passive Immunization on the Progression of Mild Alzheimer's Disease: Solanezumab (LY2062430) Versus Placebo
Status: Enrolling
Updated: 4/2/2018
Albuquerque Neurosciences
mi
from
Albuquerque, NM
Click here to add this to my saved trials
Progress of Mild Alzheimer's Disease in Participants on Solanezumab Versus Placebo
Effect of Passive Immunization on the Progression of Mild Alzheimer's Disease: Solanezumab (LY2062430) Versus Placebo
Status: Enrolling
Updated:  4/2/2018
Albany Medical College
mi
from
Albany, NY
Progress of Mild Alzheimer's Disease in Participants on Solanezumab Versus Placebo
Effect of Passive Immunization on the Progression of Mild Alzheimer's Disease: Solanezumab (LY2062430) Versus Placebo
Status: Enrolling
Updated: 4/2/2018
Albany Medical College
mi
from
Albany, NY
Click here to add this to my saved trials
Progress of Mild Alzheimer's Disease in Participants on Solanezumab Versus Placebo
Effect of Passive Immunization on the Progression of Mild Alzheimer's Disease: Solanezumab (LY2062430) Versus Placebo
Status: Enrolling
Updated:  4/2/2018
Dent Neurological Institute
mi
from
Amherst, NY
Progress of Mild Alzheimer's Disease in Participants on Solanezumab Versus Placebo
Effect of Passive Immunization on the Progression of Mild Alzheimer's Disease: Solanezumab (LY2062430) Versus Placebo
Status: Enrolling
Updated: 4/2/2018
Dent Neurological Institute
mi
from
Amherst, NY
Click here to add this to my saved trials
Progress of Mild Alzheimer's Disease in Participants on Solanezumab Versus Placebo
Effect of Passive Immunization on the Progression of Mild Alzheimer's Disease: Solanezumab (LY2062430) Versus Placebo
Status: Enrolling
Updated:  4/2/2018
SPRI Clinical Trials LLC
mi
from
Brooklyn, NY
Progress of Mild Alzheimer's Disease in Participants on Solanezumab Versus Placebo
Effect of Passive Immunization on the Progression of Mild Alzheimer's Disease: Solanezumab (LY2062430) Versus Placebo
Status: Enrolling
Updated: 4/2/2018
SPRI Clinical Trials LLC
mi
from
Brooklyn, NY
Click here to add this to my saved trials
Progress of Mild Alzheimer's Disease in Participants on Solanezumab Versus Placebo
Effect of Passive Immunization on the Progression of Mild Alzheimer's Disease: Solanezumab (LY2062430) Versus Placebo
Status: Enrolling
Updated:  4/2/2018
Columbia University Medical Center
mi
from
New York, NY
Progress of Mild Alzheimer's Disease in Participants on Solanezumab Versus Placebo
Effect of Passive Immunization on the Progression of Mild Alzheimer's Disease: Solanezumab (LY2062430) Versus Placebo
Status: Enrolling
Updated: 4/2/2018
Columbia University Medical Center
mi
from
New York, NY
Click here to add this to my saved trials
Progress of Mild Alzheimer's Disease in Participants on Solanezumab Versus Placebo
Effect of Passive Immunization on the Progression of Mild Alzheimer's Disease: Solanezumab (LY2062430) Versus Placebo
Status: Enrolling
Updated:  4/2/2018
Mount Sinai Hospital
mi
from
New York, NY
Progress of Mild Alzheimer's Disease in Participants on Solanezumab Versus Placebo
Effect of Passive Immunization on the Progression of Mild Alzheimer's Disease: Solanezumab (LY2062430) Versus Placebo
Status: Enrolling
Updated: 4/2/2018
Mount Sinai Hospital
mi
from
New York, NY
Click here to add this to my saved trials
Progress of Mild Alzheimer's Disease in Participants on Solanezumab Versus Placebo
Effect of Passive Immunization on the Progression of Mild Alzheimer's Disease: Solanezumab (LY2062430) Versus Placebo
Status: Enrolling
Updated:  4/2/2018
Richmond Behavorial Associates
mi
from
Staten Island, NY
Progress of Mild Alzheimer's Disease in Participants on Solanezumab Versus Placebo
Effect of Passive Immunization on the Progression of Mild Alzheimer's Disease: Solanezumab (LY2062430) Versus Placebo
Status: Enrolling
Updated: 4/2/2018
Richmond Behavorial Associates
mi
from
Staten Island, NY
Click here to add this to my saved trials
Progress of Mild Alzheimer's Disease in Participants on Solanezumab Versus Placebo
Effect of Passive Immunization on the Progression of Mild Alzheimer's Disease: Solanezumab (LY2062430) Versus Placebo
Status: Enrolling
Updated:  4/2/2018
Behavioral Health Center Research
mi
from
Charlotte, NC
Progress of Mild Alzheimer's Disease in Participants on Solanezumab Versus Placebo
Effect of Passive Immunization on the Progression of Mild Alzheimer's Disease: Solanezumab (LY2062430) Versus Placebo
Status: Enrolling
Updated: 4/2/2018
Behavioral Health Center Research
mi
from
Charlotte, NC
Click here to add this to my saved trials
Progress of Mild Alzheimer's Disease in Participants on Solanezumab Versus Placebo
Effect of Passive Immunization on the Progression of Mild Alzheimer's Disease: Solanezumab (LY2062430) Versus Placebo
Status: Enrolling
Updated:  4/2/2018
Pmg Research Of Charlotte
mi
from
Charlotte, NC
Progress of Mild Alzheimer's Disease in Participants on Solanezumab Versus Placebo
Effect of Passive Immunization on the Progression of Mild Alzheimer's Disease: Solanezumab (LY2062430) Versus Placebo
Status: Enrolling
Updated: 4/2/2018
Pmg Research Of Charlotte
mi
from
Charlotte, NC
Click here to add this to my saved trials
Progress of Mild Alzheimer's Disease in Participants on Solanezumab Versus Placebo
Effect of Passive Immunization on the Progression of Mild Alzheimer's Disease: Solanezumab (LY2062430) Versus Placebo
Status: Enrolling
Updated:  4/2/2018
Guilford Neurologic Associates, Inc.
mi
from
Greensboro, NC
Progress of Mild Alzheimer's Disease in Participants on Solanezumab Versus Placebo
Effect of Passive Immunization on the Progression of Mild Alzheimer's Disease: Solanezumab (LY2062430) Versus Placebo
Status: Enrolling
Updated: 4/2/2018
Guilford Neurologic Associates, Inc.
mi
from
Greensboro, NC
Click here to add this to my saved trials
Progress of Mild Alzheimer's Disease in Participants on Solanezumab Versus Placebo
Effect of Passive Immunization on the Progression of Mild Alzheimer's Disease: Solanezumab (LY2062430) Versus Placebo
Status: Enrolling
Updated:  4/2/2018
Wake Research Associates, LLC
mi
from
Raleigh, NC
Progress of Mild Alzheimer's Disease in Participants on Solanezumab Versus Placebo
Effect of Passive Immunization on the Progression of Mild Alzheimer's Disease: Solanezumab (LY2062430) Versus Placebo
Status: Enrolling
Updated: 4/2/2018
Wake Research Associates, LLC
mi
from
Raleigh, NC
Click here to add this to my saved trials
Progress of Mild Alzheimer's Disease in Participants on Solanezumab Versus Placebo
Effect of Passive Immunization on the Progression of Mild Alzheimer's Disease: Solanezumab (LY2062430) Versus Placebo
Status: Enrolling
Updated:  4/2/2018
PMG Research of Winston-Salem
mi
from
Winston-Salem, NC
Progress of Mild Alzheimer's Disease in Participants on Solanezumab Versus Placebo
Effect of Passive Immunization on the Progression of Mild Alzheimer's Disease: Solanezumab (LY2062430) Versus Placebo
Status: Enrolling
Updated: 4/2/2018
PMG Research of Winston-Salem
mi
from
Winston-Salem, NC
Click here to add this to my saved trials
Progress of Mild Alzheimer's Disease in Participants on Solanezumab Versus Placebo
Effect of Passive Immunization on the Progression of Mild Alzheimer's Disease: Solanezumab (LY2062430) Versus Placebo
Status: Enrolling
Updated:  4/2/2018
Valley Medical Research
mi
from
Centerville, OH
Progress of Mild Alzheimer's Disease in Participants on Solanezumab Versus Placebo
Effect of Passive Immunization on the Progression of Mild Alzheimer's Disease: Solanezumab (LY2062430) Versus Placebo
Status: Enrolling
Updated: 4/2/2018
Valley Medical Research
mi
from
Centerville, OH
Click here to add this to my saved trials
Progress of Mild Alzheimer's Disease in Participants on Solanezumab Versus Placebo
Effect of Passive Immunization on the Progression of Mild Alzheimer's Disease: Solanezumab (LY2062430) Versus Placebo
Status: Enrolling
Updated:  4/2/2018
The Ohio State University College of Medicine
mi
from
Columbus, OH
Progress of Mild Alzheimer's Disease in Participants on Solanezumab Versus Placebo
Effect of Passive Immunization on the Progression of Mild Alzheimer's Disease: Solanezumab (LY2062430) Versus Placebo
Status: Enrolling
Updated: 4/2/2018
The Ohio State University College of Medicine
mi
from
Columbus, OH
Click here to add this to my saved trials
Progress of Mild Alzheimer's Disease in Participants on Solanezumab Versus Placebo
Effect of Passive Immunization on the Progression of Mild Alzheimer's Disease: Solanezumab (LY2062430) Versus Placebo
Status: Enrolling
Updated:  4/2/2018
Neurology Specialists
mi
from
Dayton, OH
Progress of Mild Alzheimer's Disease in Participants on Solanezumab Versus Placebo
Effect of Passive Immunization on the Progression of Mild Alzheimer's Disease: Solanezumab (LY2062430) Versus Placebo
Status: Enrolling
Updated: 4/2/2018
Neurology Specialists
mi
from
Dayton, OH
Click here to add this to my saved trials
Progress of Mild Alzheimer's Disease in Participants on Solanezumab Versus Placebo
Effect of Passive Immunization on the Progression of Mild Alzheimer's Disease: Solanezumab (LY2062430) Versus Placebo
Status: Enrolling
Updated:  4/2/2018
Insight Clinical Trials
mi
from
Shaker Heights, OH
Progress of Mild Alzheimer's Disease in Participants on Solanezumab Versus Placebo
Effect of Passive Immunization on the Progression of Mild Alzheimer's Disease: Solanezumab (LY2062430) Versus Placebo
Status: Enrolling
Updated: 4/2/2018
Insight Clinical Trials
mi
from
Shaker Heights, OH
Click here to add this to my saved trials
Progress of Mild Alzheimer's Disease in Participants on Solanezumab Versus Placebo
Effect of Passive Immunization on the Progression of Mild Alzheimer's Disease: Solanezumab (LY2062430) Versus Placebo
Status: Enrolling
Updated:  4/2/2018
Cutting Edge Research Group
mi
from
Oklahoma City, OK
Progress of Mild Alzheimer's Disease in Participants on Solanezumab Versus Placebo
Effect of Passive Immunization on the Progression of Mild Alzheimer's Disease: Solanezumab (LY2062430) Versus Placebo
Status: Enrolling
Updated: 4/2/2018
Cutting Edge Research Group
mi
from
Oklahoma City, OK
Click here to add this to my saved trials
Progress of Mild Alzheimer's Disease in Participants on Solanezumab Versus Placebo
Effect of Passive Immunization on the Progression of Mild Alzheimer's Disease: Solanezumab (LY2062430) Versus Placebo
Status: Enrolling
Updated:  4/2/2018
Red River Medical Center, LLC
mi
from
Oklahoma City, OK
Progress of Mild Alzheimer's Disease in Participants on Solanezumab Versus Placebo
Effect of Passive Immunization on the Progression of Mild Alzheimer's Disease: Solanezumab (LY2062430) Versus Placebo
Status: Enrolling
Updated: 4/2/2018
Red River Medical Center, LLC
mi
from
Oklahoma City, OK
Click here to add this to my saved trials
Progress of Mild Alzheimer's Disease in Participants on Solanezumab Versus Placebo
Effect of Passive Immunization on the Progression of Mild Alzheimer's Disease: Solanezumab (LY2062430) Versus Placebo
Status: Enrolling
Updated:  4/2/2018
The Corvallis Clinic, PC
mi
from
Corvallis, OR
Progress of Mild Alzheimer's Disease in Participants on Solanezumab Versus Placebo
Effect of Passive Immunization on the Progression of Mild Alzheimer's Disease: Solanezumab (LY2062430) Versus Placebo
Status: Enrolling
Updated: 4/2/2018
The Corvallis Clinic, PC
mi
from
Corvallis, OR
Click here to add this to my saved trials
Progress of Mild Alzheimer's Disease in Participants on Solanezumab Versus Placebo
Effect of Passive Immunization on the Progression of Mild Alzheimer's Disease: Solanezumab (LY2062430) Versus Placebo
Status: Enrolling
Updated:  4/2/2018
Summit Research Network
mi
from
Portland, OR
Progress of Mild Alzheimer's Disease in Participants on Solanezumab Versus Placebo
Effect of Passive Immunization on the Progression of Mild Alzheimer's Disease: Solanezumab (LY2062430) Versus Placebo
Status: Enrolling
Updated: 4/2/2018
Summit Research Network
mi
from
Portland, OR
Click here to add this to my saved trials
Progress of Mild Alzheimer's Disease in Participants on Solanezumab Versus Placebo
Effect of Passive Immunization on the Progression of Mild Alzheimer's Disease: Solanezumab (LY2062430) Versus Placebo
Status: Enrolling
Updated:  4/2/2018
Drexel University College of Medicine at EPPI
mi
from
Philadelphia, PA
Progress of Mild Alzheimer's Disease in Participants on Solanezumab Versus Placebo
Effect of Passive Immunization on the Progression of Mild Alzheimer's Disease: Solanezumab (LY2062430) Versus Placebo
Status: Enrolling
Updated: 4/2/2018
Drexel University College of Medicine at EPPI
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Progress of Mild Alzheimer's Disease in Participants on Solanezumab Versus Placebo
Effect of Passive Immunization on the Progression of Mild Alzheimer's Disease: Solanezumab (LY2062430) Versus Placebo
Status: Enrolling
Updated:  4/2/2018
University of Pittsburgh Medical Center
mi
from
Pittsburgh, PA
Progress of Mild Alzheimer's Disease in Participants on Solanezumab Versus Placebo
Effect of Passive Immunization on the Progression of Mild Alzheimer's Disease: Solanezumab (LY2062430) Versus Placebo
Status: Enrolling
Updated: 4/2/2018
University of Pittsburgh Medical Center
mi
from
Pittsburgh, PA
Click here to add this to my saved trials
Progress of Mild Alzheimer's Disease in Participants on Solanezumab Versus Placebo
Effect of Passive Immunization on the Progression of Mild Alzheimer's Disease: Solanezumab (LY2062430) Versus Placebo
Status: Enrolling
Updated:  4/2/2018
Rhode Island Mood & Memory Research Institute
mi
from
East Providence, RI
Progress of Mild Alzheimer's Disease in Participants on Solanezumab Versus Placebo
Effect of Passive Immunization on the Progression of Mild Alzheimer's Disease: Solanezumab (LY2062430) Versus Placebo
Status: Enrolling
Updated: 4/2/2018
Rhode Island Mood & Memory Research Institute
mi
from
East Providence, RI
Click here to add this to my saved trials
Progress of Mild Alzheimer's Disease in Participants on Solanezumab Versus Placebo
Effect of Passive Immunization on the Progression of Mild Alzheimer's Disease: Solanezumab (LY2062430) Versus Placebo
Status: Enrolling
Updated:  4/2/2018
Butler Hospital
mi
from
Providence, RI
Progress of Mild Alzheimer's Disease in Participants on Solanezumab Versus Placebo
Effect of Passive Immunization on the Progression of Mild Alzheimer's Disease: Solanezumab (LY2062430) Versus Placebo
Status: Enrolling
Updated: 4/2/2018
Butler Hospital
mi
from
Providence, RI
Click here to add this to my saved trials
Progress of Mild Alzheimer's Disease in Participants on Solanezumab Versus Placebo
Effect of Passive Immunization on the Progression of Mild Alzheimer's Disease: Solanezumab (LY2062430) Versus Placebo
Status: Enrolling
Updated:  4/2/2018
Rhode Island Hospital
mi
from
Providence, RI
Progress of Mild Alzheimer's Disease in Participants on Solanezumab Versus Placebo
Effect of Passive Immunization on the Progression of Mild Alzheimer's Disease: Solanezumab (LY2062430) Versus Placebo
Status: Enrolling
Updated: 4/2/2018
Rhode Island Hospital
mi
from
Providence, RI
Click here to add this to my saved trials
Progress of Mild Alzheimer's Disease in Participants on Solanezumab Versus Placebo
Effect of Passive Immunization on the Progression of Mild Alzheimer's Disease: Solanezumab (LY2062430) Versus Placebo
Status: Enrolling
Updated:  4/2/2018
Roper St. Francis Healthcare
mi
from
Charleston, SC
Progress of Mild Alzheimer's Disease in Participants on Solanezumab Versus Placebo
Effect of Passive Immunization on the Progression of Mild Alzheimer's Disease: Solanezumab (LY2062430) Versus Placebo
Status: Enrolling
Updated: 4/2/2018
Roper St. Francis Healthcare
mi
from
Charleston, SC
Click here to add this to my saved trials
Progress of Mild Alzheimer's Disease in Participants on Solanezumab Versus Placebo
Effect of Passive Immunization on the Progression of Mild Alzheimer's Disease: Solanezumab (LY2062430) Versus Placebo
Status: Enrolling
Updated:  4/2/2018
Radiant Research
mi
from
Greer, SC
Progress of Mild Alzheimer's Disease in Participants on Solanezumab Versus Placebo
Effect of Passive Immunization on the Progression of Mild Alzheimer's Disease: Solanezumab (LY2062430) Versus Placebo
Status: Enrolling
Updated: 4/2/2018
Radiant Research
mi
from
Greer, SC
Click here to add this to my saved trials
Progress of Mild Alzheimer's Disease in Participants on Solanezumab Versus Placebo
Effect of Passive Immunization on the Progression of Mild Alzheimer's Disease: Solanezumab (LY2062430) Versus Placebo
Status: Enrolling
Updated:  4/2/2018
University Psychiatry Associates Avera Health
mi
from
Sioux Falls, SD
Progress of Mild Alzheimer's Disease in Participants on Solanezumab Versus Placebo
Effect of Passive Immunization on the Progression of Mild Alzheimer's Disease: Solanezumab (LY2062430) Versus Placebo
Status: Enrolling
Updated: 4/2/2018
University Psychiatry Associates Avera Health
mi
from
Sioux Falls, SD
Click here to add this to my saved trials